419 related articles for article (PubMed ID: 18076314)
1. Glioblastoma multiforme: evidence-based approach to therapy.
Nicholas MK
Expert Rev Anticancer Ther; 2007 Dec; 7(12 Suppl):S23-7. PubMed ID: 18076314
[TBL] [Abstract][Full Text] [Related]
2. Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26).
Vordermark D; Ruprecht K; Rieckmann P; Roggendorf W; Vince GH; Warmuth-Metz M; Kölbl O; Flentje M
BMC Cancer; 2006 Oct; 6():247. PubMed ID: 17049083
[TBL] [Abstract][Full Text] [Related]
3. Photon radiotherapy for the treatment of high-grade gliomas.
Hwang CS; Marymont MH; Muro K
Expert Rev Anticancer Ther; 2007 Dec; 7(12 Suppl):S37-43. PubMed ID: 18076317
[TBL] [Abstract][Full Text] [Related]
4. Clinical trials for glioblastoma multiforme using adenoviral vectors.
Wirth T; Samaranayake H; Pikkarainen J; Määttä AM; Ylä-Herttuala S
Curr Opin Mol Ther; 2009 Oct; 11(5):485-92. PubMed ID: 19806496
[TBL] [Abstract][Full Text] [Related]
5. Spectrum of pediatric gliomas: implications for the development of future therapies.
Pytel P
Expert Rev Anticancer Ther; 2007 Dec; 7(12 Suppl):S51-60. PubMed ID: 18076319
[TBL] [Abstract][Full Text] [Related]
6. Glioblastoma multiforme: a review of where we have been and where we are going.
Adamson C; Kanu OO; Mehta AI; Di C; Lin N; Mattox AK; Bigner DD
Expert Opin Investig Drugs; 2009 Aug; 18(8):1061-83. PubMed ID: 19555299
[TBL] [Abstract][Full Text] [Related]
7. Impact of PARP-1 and DNA-PK expression on survival in patients with glioblastoma multiforme.
Kase M; Vardja M; Lipping A; Asser T; Jaal J
Radiother Oncol; 2011 Oct; 101(1):127-31. PubMed ID: 21775006
[TBL] [Abstract][Full Text] [Related]
8. Is older age associated with a worse prognosis due to different patterns of care? A long-term study of 1346 patients with glioblastomas or brain metastases.
Lutterbach J; Bartelt S; Momm F; Becker G; Frommhold H; Ostertag C
Cancer; 2005 Mar; 103(6):1234-44. PubMed ID: 15666327
[TBL] [Abstract][Full Text] [Related]
9. Institutional experience with chloroquine as an adjuvant to the therapy for glioblastoma multiforme.
Briceño E; Calderon A; Sotelo J
Surg Neurol; 2007 Apr; 67(4):388-91. PubMed ID: 17350410
[TBL] [Abstract][Full Text] [Related]
10. Lack of survival benefit after stereotactic radiosurgery boost for glioblastoma multiforme: randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of radiation therapy oncology group 93-05 protocol: in regard to Souhami et al. (Int J Radiat Oncol Biol Phys 2004;60:853-860).
Vordermark D; Kölbl O
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):296-7; author reply 297. PubMed ID: 15850943
[No Abstract] [Full Text] [Related]
11. Clinical practice experience with NovoTTF-100A™ system for glioblastoma: The Patient Registry Dataset (PRiDe).
Mrugala MM; Engelhard HH; Dinh Tran D; Kew Y; Cavaliere R; Villano JL; Annenelie Bota D; Rudnick J; Love Sumrall A; Zhu JJ; Butowski N
Semin Oncol; 2014 Oct; 41 Suppl 6():S4-S13. PubMed ID: 25213869
[TBL] [Abstract][Full Text] [Related]
12. Radiation and Immunotherapy in High-grade Gliomas: Where Do We Stand?
Reznik E; Smith AW; Taube S; Mann J; Yondorf MZ; Parashar B; Wernicke AG
Am J Clin Oncol; 2018 Feb; 41(2):197-212. PubMed ID: 28906259
[TBL] [Abstract][Full Text] [Related]
13. Emerging therapies for malignant glioma.
Lukas RV; Boire A; Nicholas MK
Expert Rev Anticancer Ther; 2007 Dec; 7(12 Suppl):S29-36. PubMed ID: 18076315
[TBL] [Abstract][Full Text] [Related]
14. Treatment of glioblastoma multiforme: a new standard.
Henson JW
Arch Neurol; 2006 Mar; 63(3):337-41. PubMed ID: 16533960
[No Abstract] [Full Text] [Related]
15. Glioblastoma therapy: going beyond Hercules Columns.
Mangiola A; Anile C; Pompucci A; Capone G; Rigante L; De Bonis P
Expert Rev Neurother; 2010 Apr; 10(4):507-14. PubMed ID: 20367204
[TBL] [Abstract][Full Text] [Related]
16. Patterns of care and predictors of adjuvant therapies in elderly patients with glioblastoma: An analysis of the National Cancer Data Base.
Amsbaugh MJ; Yusuf MB; Gaskins J; Burton EC; Woo SY
Cancer; 2017 Sep; 123(17):3277-3284. PubMed ID: 28452053
[TBL] [Abstract][Full Text] [Related]
17. New prognostic factors and calculators for outcome prediction in patients with recurrent glioblastoma: a pooled analysis of EORTC Brain Tumour Group phase I and II clinical trials.
Gorlia T; Stupp R; Brandes AA; Rampling RR; Fumoleau P; Dittrich C; Campone MM; Twelves CC; Raymond E; Hegi ME; Lacombe D; van den Bent MJ
Eur J Cancer; 2012 May; 48(8):1176-84. PubMed ID: 22464345
[TBL] [Abstract][Full Text] [Related]
18. [Multimodal treatment of glioblastoma multiforme: results of 86 consecutive patients diagnosed in period 2003-2009].
Lakomý R; Fadrus P; Slampa P; Svoboda T; Kren L; Lzicarová E; Belanová R; Siková I; Poprach A; Schneiderová M; Procházková M; Sána J; Slabý O; Smrcka M; Vyzula R; Svoboda M
Klin Onkol; 2011; 24(2):112-20. PubMed ID: 21644366
[TBL] [Abstract][Full Text] [Related]
19. Response patterns of recurrent glioblastomas treated with tumor-treating fields.
Vymazal J; Wong ET
Semin Oncol; 2014 Oct; 41 Suppl 6():S14-24. PubMed ID: 25213870
[TBL] [Abstract][Full Text] [Related]
20. Surgical management of pediatric brain tumors.
Heuer GG; Jackson EM; Magge SN; Storm PB
Expert Rev Anticancer Ther; 2007 Dec; 7(12 Suppl):S61-8. PubMed ID: 18076320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
